Vitality Watch

Dossier pubmed preclinical 10-aug-2026
Animal model, organoid, or cell-culture result — not yet human

Dioscin extends lifespan and ameliorates aging associated phenotypes in association with the endoplasmic reticulum unfolded protein response.

Key claim: Dioscin extends C. elegans lifespan and healthspan and reduces p16/p21 senescence markers in aged mice by activating the ER unfolded protein response through XBP-1 and the PERK, IRE1α, and ATF6 branches.

Abstract

Dioscin, a naturally occurring steroidal saponin isolated from various kinds of herbs with pleiotropic pharmacological properties, remains mechanistically undefined regarding its mammalian aging modulation. This study discovered that dioscin extended the lifespan of Caenorhabditis elegans. Concurrently, dioscin improved the motor function of C. elegans and reduced age pigment accumulation, while having no effect on the reproductive performance of the C. elegans. By pathway screening, we identified that dioscin extends healthspan via the endoplasmic reticulum unfolded protein response (UPR) transcription factor XBP-1. Moreover, lifespan assays conducted on nematode mutants that the UPRkey effectors (PERK, IRE1α and ATF6) demonstrated that dioscin influences the lifespan of C. elegans through all three of these key effectors. These findings provide a foundation for further investigation into its mechanism of action in regulating mammalian aging. In this study, we used naturally aged C57BL/6 J mice in a 6-month intervention study and found that dioscin significantly reduced expression of senescence markers (p21, p16) in hepatic and skeletal muscle tissues. Furthermore, dioscin maintains proteostasis through coordinated activation of the endoplasmic reticulum unfolded protein response (UPR) key effectors (PERK, IRE1α, ATF6, and s-XBP1). Our study provides preclinical evidence supporting dioscin as a novel intervention that ameliorates aging-associated phenotypes and highlights the pivotal role of UPRin lifespan extension and aging suppression.

Why this matters

Dioscin is the first natural-product candidate to tie a C. elegans lifespan extension and an aged-mouse senescence-marker reduction specifically to coordinated activation of all three ER-UPR branches, giving the proteostasis-as-geroprotection axis a concrete small-molecule handle. The finding sits squarely in preclinical territory — invertebrate lifespan plus mouse tissue markers, no human readout — and slots into the broader question of whether UPR tone can be pharmacologically nudged without triggering the pathway’s known pro-apoptotic arm. It also extends the senescence page’s causal map upstream from DNA damage and SASP toward ER stress handling.

Source

Link

Briefing card

Dioscin extends lifespan and ameliorates aging associated phenotypes in association with the endoplasmic reticulum unfolded protein response.
Stage: preclinical · pubmed · 10-aug-2026

Dioscin extends C. elegans lifespan and healthspan and reduces p16/p21 senescence markers in aged mice by activating the ER unfolded protein response through XBP-1 and the PERK, IRE1α, and ATF6 branches.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.exger.2026.113275

build build 880 · 2bcef25 · 2026-11-18